NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/12/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3,951.9 mln
Float96.25 mln
Earnings Date08/07/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
17.09
Highly suspicious
Relative Strength
22
/ 100
Significantly lagging
Debt / Equity
0.04
Debt-free
ROE
-43.01
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Crinetics Pharmaceuticals is a San Diego-based drug development company working to bring new oral treatments to patients with rare hormonal disorders and related tumors. Its most advanced program is Paltusotine, a pill being tested in late-stage clinical trials for conditions such as acromegaly and hormone-secreting tumors, with commercialization rights in Japan licensed to Sanwa Kagaku Kenkyusho. The company's broader pipeline targets a range of hormonal diseases ? including Cushing's disease, Graves' disease, polycystic kidney disease, and obesity ? through several additional drug candidates at various stages of development.
